skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
03/12/2024
Application #:
18340722
Filing Dt:
06/23/2023
Publication #:
Pub Dt:
12/07/2023
Inventors:
William Louis MACIAS, Su LIANG, Hyeakyung AHN, Haeyoung YONG, Mijin JUNG, Minho YOON et al
Title:
ANTI-FcRn ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF WITH IMPROVED STABILITY
Assignment: 1
Reel/Frame:
065006/0327Recorded: 09/25/2023Pages: 8
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
06/02/2023
Assignee:
VIADUKTSTRASSE 8
BASEL, SWITZERLAND 4051
Correspondent:
COOLEY LLP
1299 PENNSYLVANIA AVENUE
COOLEY LLP
WASHINGTON, DC 20004
Assignment: 2
Reel/Frame:
065006/0292Recorded: 09/25/2023Pages: 9
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
06/05/2023
Exec Dt:
06/07/2023
Assignee:
320 WEST 37TH STREET
6TH FLOOR
NEW YORK, NEW YORK 10018
Correspondent:
COOLEY LLP
1299 PENNSYLVANIA AVENUE
COOLEY LLP
WASHINGTON, DC 20004
Assignment: 3
Reel/Frame:
065006/0241Recorded: 09/25/2023Pages: 14
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
06/06/2023
Exec Dt:
06/06/2023
Exec Dt:
06/06/2023
Exec Dt:
06/06/2023
Exec Dt:
06/06/2023
Exec Dt:
06/06/2023
Exec Dt:
06/08/2023
Assignee:
43, SANGSEODANG 1-GIL DAEDEOK-GU
DAEJEON, KOREA, REPUBLIC OF 306-120
Correspondent:
COOLEY LLP
1299 PENNSYLVANIA AVENUE
COOLEY LLP
WASHINGTON, DC 20004

Search Results as of: 05/22/2024 01:19 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT